Table 1 Characteristics of reported cVDPV2 cases from north and south Yemen, 2021–2022
Whole country | North | South | ||||
|---|---|---|---|---|---|---|
Cases of cVDPVs | ||||||
Characteristics | No. | % | No. | % | No. | % |
227 | 100% | 195 | 86% | 32 | 14% | |
Year | ||||||
2021 | 65 | 29% | 40 | 21% | 25 | 78% |
2022 | 162 | 71% | 155 | 79% | 7 | 22% |
Age group | ||||||
< 5 Ys | 207 | 91% | 179 | 92% | 28 | 88% |
> 5 Ys | 20 | 9% | 16 | 8% | 4 | 12% |
Sex | ||||||
Male | 142 | 63% | 124 | 64% | 18 | 56% |
Female | 85 | 37% | 71 | 36% | 14 | 44% |
IPV in RI | ||||||
Zero dose | 187 | 82% | 158 | 81% | 29 | 91% |
One dose | 40 | 18% | 37 | 19% | 3 | 9% |
Main AFP surveillance indicators | ||||||
Years | NPAFP rate 6.6 | %ADEQ 87.5% | NPAFP rate 6.7 | %ADEQ 87% | NPAFP rate 6.4 | %ADEQ 88.5% |
2021 | 5.5 | 88% | 5.6 | 87% | 5.3 | 89% |
2022 | 7.7 | 87% | 7.8 | 87% | 7.4 | 86% |